Fifth Amendment to Specialty Pharmacy Network Agreement, dated as of August 2, 2023, between the Registrant and Accredo Health Group, Inc
EX-10.1 2 uthrex10109302023.htm EX-10.1 Document
Exhibit 10.1
FIFTH AMENDMENT
TO
SPECIALTY PHARMACY NETWORK AGREEMENT
This Fifth Amendment to Specialty Pharmacy Network Agreement (this “Amendment”) is made as of the date the last Party executes this Amendment (the “Amendment Effective Date”), by and between Accredo Health Group, Inc. (“Specialty Pharmacy”), and United Therapeutics Corporation (“UT”). Specialty Pharmacy and UT are each referred to in this Agreement as a “Party,” collectively, the “Parties.”
WHEREAS, the Parties entered into that certain Specialty Pharmacy Network Agreement dated as of January 1, 2018, as amended (the “Agreement”); and
WHEREAS, the Parties entered into that certain Master Services Agreement dated December 18, 2013 as amended (the “Master Services Agreement”); and
WHEREAS, the Parties now wish to amend the Agreement to remove safety information reporting requirements given that these requirements have been moved to the Master Services Agreement.
NOW THEREFORE, in consideration of the mutual agreements and covenants contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto, intending to be legally bound, hereby agree as follows:
1.Definitions. Sections 1.1 (a) “Adverse Drug Reaction (ADR)/Adverse Reaction/Suspect Adverse (Drug) Reaction”, (b) “Adverse Event/Adverse Drug Experience (AE)”, (k) “Day 0”, (v) “Product Complaint or PC”, (w) “Safety Information”, and (y) “Service Fees” of the Agreement are hereby deleted and replaced with “Intentionally Omitted.”
2.Safety Information Reporting. Section 7.3 of the Agreement is hereby deleted and replaced with “Intentionally Omitted.”
3.Service Fees. Section 17 “Service Fees, Invoices and Payment” is hereby deleted in its entirety.
4.Attachment A. Attachment A is hereby deleted in its entirety and is replaced with the Attachment A attached hereto.
5.Attachment H. Attachment H is hereby deleted in its entirety and is replaced with the Attachment H attached hereto.
6.Attachments. Attachments D, F, & G are hereby deleted and replaced with “Intentionally Omitted.”
7.Except as amended and supplemented hereby, all of the terms and conditions of the Agreement shall remain and continue in full force and effect and apply hereto.
(Signature Page to Follow)
Page 1 of 7
Exhibit 10.1
IN WITNESS WHEREOF, each of the undersigned, duly authorized, has executed this Amendment, effective as of the Amendment Effective Date.
Accredo Health Group, Inc. By: __/s/ Michael Hughes____________ Print Name: Michael Hughes Title: Managing Director Date: __8/2/2023_____________________ | United Therapeutics Corporation By: __/s/ Kevin T. Gray_____________ Print Name: Kevin T. Gray Title: SVP, Strategic Operations Date: _8/2/23_________________________ | ||||
Page 2 of 7
